Drawing for GRINDEX

USPTO serial 79010441

GRINDEX

Reviewed by CopyMark Law Group

Reg. 3158923Status 404
Filing date
Status date
Registration date
Oct 17, 2006
Examiner
HAMMEL, LAURA A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GRINDEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

G PATRICK SAGE

G PATRICK SAGE HUESCHEN & SAGE PLLC107 W MICHIGAN AVE 7TH FL KALAMAZOO BLDGKALAMAZOO, MI 49007UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for research purposesSECTION 71 - CANCELLED
005Biological preparations for pharmaceutical purposes; veterinary preparations for the prophylaxis and treatment of cardiological, cardiovascular, antiischemic and neurological diseases for use in treating all animals; diagnostic preparations for medical purposes; medicinal herb extract; medicinal herbs in dried or preserved form; pharmaceutical preparations for the prophylaxis and treatment of cardiological, cardiovascular, antiischemic and neurological diseases, certain infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, disease of the genitourinary system, certain conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities injury, and poisoningSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 27, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jun 27, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
Jun 1, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB
Apr 16, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 5, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 13, 2014XXSSGENERIC MADRID TRANSACTION SENT TO IB
Sep 13, 2014XXCRGENERIC MADRID TRANSACTION CREATED
Jun 19, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED
May 13, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 13, 2013C71TCANCELLED SECTION 71
Dec 24, 2010RNWLINTERNATIONAL REGISTRATION RENEWED
Jun 19, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 18, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB
May 18, 2007FIMPFINAL DISPOSITION PROCESSED
May 9, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 10, 2006CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Jul 25, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 5, 2006NPUBNOTICE OF PUBLICATION
Jun 2, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
May 19, 2006ALIEASSIGNED TO LIE
May 15, 2006CNEAEXAMINERS AMENDMENT MAILED
May 15, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2006XAECEXAMINER'S AMENDMENT ENTERED
May 15, 2006CNEAEXAMINERS AMENDMENT -WRITTEN
Apr 28, 2006CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 28, 2006CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 10, 2006ACECAMENDMENT FROM APPLICANT ENTERED
Mar 17, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2006MAILPAPER RECEIVED
Nov 4, 2005RFNTREFUSAL PROCESSED BY IB
Oct 17, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 15, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 14, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 12, 2005DOCKASSIGNED TO EXAMINER
May 27, 2005NWAPNEW APPLICATION ENTERED
May 26, 2005SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance